How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Do you agree with the proposal not to update the guideline?

  • Question on Consultation

    Do you have any comments on areas excluded from the scope of the guideline?

  • Question on Consultation

    Do you have any comments on equality issues?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Summary of evidence for 2019 surveillance of menopause (2015) NICE guideline NG23

Closed for comments This consultation ended on at   Request commenting lead permission

Overview

Studies identified in searches are summarised from the information presented in their abstracts. We did not specify any age limits on HRT treatment because this information was not consistently reported clearly across the abstracts.

Because of a large volume of evidence, we excluded randomised controlled trials that included less than 100 people.

Feedback from topic experts who advised us on the approach to this surveillance review, was considered alongside the evidence to reach a view on the need to update each section of the guideline.

See the evidence tables for all studies considered in surveillance.